A patient who recently underwent a bone marrow transplant presents with fever, fatigue, mild jaundice, and diminished breath sounds at the lung bases. Laboratory tests reveal elevated liver enzymes and leukopenia. What should be the nurse's priority assessment to address the patient's current symptoms and prevent further complications?

B) Evaluate the patient for signs of infection and report findings to the healthcare provider.

A) Monitor fluid intake and output to assess for fluid overload.

B) Evaluate the patient for signs of infection and report findings to the healthcare provider.

C) Adjust the patient's oxygen delivery method to improve oxygen saturation.

D) Review the patient's medication regimen for potential nephrotoxicity.

A patient who recently received a bone marrow transplant presents with fever, fatigue, pallor, mild jaundice, and diminished breath sounds. Laboratory results indicate elevated liver enzymes and leukopenia. Imaging shows bilateral pulmonary infiltrates. Which nursing intervention should be prioritized to address the patient's current clinical condition and potential complications?

A) Administer broad-spectrum antibiotics to prevent opportunistic infections.

B) Increase the dose of immunosuppressive medications to manage potential graft-versus-host disease (GVHD).

C) Provide supplemental oxygen to improve oxygen saturation levels.

D) Initiate diuretic therapy to manage fluid overload and pulmonary infiltrates.

A post-transplant patient is experiencing deteriorating respiratory function, increased liver enzymes, and jaundice. Which nursing intervention is most critical to address her current condition?

B) Prepare for potential mechanical ventilation due to worsening respiratory status.

A) Administer broad-spectrum antibiotics to address potential pulmonary infection.

B) Prepare for potential mechanical ventilation due to worsening respiratory status.

C) Increase the dosage of Mycophenolate mofetil to prevent GVHD progression.

D) Initiate aggressive diuretic therapy to manage hepatic congestion.

A patient post-bone marrow transplant is exhibiting signs of respiratory distress and hepatic dysfunction. Despite receiving broad-spectrum antibiotics and diuretics, her respiratory status continues to worsen, and she presents with jaundice and elevated liver enzymes. The healthcare team suspects veno-occlusive disease (VOD) and has adjusted her immunosuppressive regimen. What is the priority nursing intervention to address the patient's current respiratory status?

B) Position the patient in a high Fowler's position to facilitate easier breathing

A) Increase supplemental oxygen delivery to maintain oxygen saturation levels above 92%

B) Position the patient in a high Fowler's position to facilitate easier breathing

C) Prepare for potential escalation to mechanical ventilation

D) Monitor liver function tests closely to assess for further deterioration

A post-transplant patient with confirmed veno-occlusive disease (VOD) and acute respiratory distress syndrome (ARDS) is receiving defibrotide therapy. Her recent lab results show an elevated INR and decreased platelet count. Which nursing intervention is the most critical to prioritize in managing this patient's care?

B) Monitor for signs of bleeding and adjust anticoagulant therapy as necessary.

A) Administer vitamin K to correct the elevated INR.

B) Monitor for signs of bleeding and adjust anticoagulant therapy as necessary.

C) Increase the dosage of diuretics to manage fluid overload.

D) Initiate nutritional support to improve liver function.

A post-transplant patient with confirmed veno-occlusive disease (VOD) and suspected graft-versus-host disease (GVHD) presents with severe hypoxemia and respiratory acidosis. The patient is currently on defibrotide therapy and non-invasive positive pressure ventilation (NIPPV) has been initiated. Considering the patient's complex condition, which nursing intervention is a priority to optimize her respiratory status?

B) Monitor vital signs and oxygen saturation continuously while assessing for signs of respiratory distress.

A) Increase the patient's fluid intake to support renal function.

B) Monitor vital signs and oxygen saturation continuously while assessing for signs of respiratory distress.

C) Encourage the patient to perform deep breathing exercises to improve lung expansion.

D) Administer a high-protein diet to promote healing and recovery.

A patient with worsening ARDS and hepatic involvement due to VOD is being intubated. Considering her complex condition, what is the priority nursing intervention immediately post-intubation?

B) Monitor arterial blood gases and adjust ventilator settings as needed.

A) Administer a higher dose of corticosteroids to reduce inflammation.

B) Monitor arterial blood gases and adjust ventilator settings as needed.

C) Initiate plasmapheresis to address the liver function derangement.

D) Increase IV fluid rate to improve renal function.

A patient with acute respiratory distress syndrome (ARDS) and worsening liver and renal function is being prepared for intubation. Which nursing intervention is most important to prioritize before the procedure?

B) Verify the availability of emergency resuscitation equipment

A) Administer a sedative to ensure patient comfort

B) Verify the availability of emergency resuscitation equipment

C) Review the patient's allergy history to prevent adverse reactions

D) Obtain a baseline set of vital signs to monitor post-procedure changes

A patient in the ICU is on mechanical ventilation with lung-protective strategies and has developed hemodynamic instability with hypotension and tachycardia. The medical team has initiated norepinephrine for vasopressor support. Which nursing intervention is most appropriate to monitor the effectiveness of the vasopressor therapy?

A) Measure urine output hourly to assess renal perfusion.

B) Increase fluid intake to counteract vasoconstriction.

C) Decrease norepinephrine dosage if blood pressure improves.

D) Monitor arterial blood gases for improved oxygenation.

A patient in the intensive care unit is experiencing mixed respiratory and metabolic acidosis with hemodynamic instability. The medical team has adjusted ventilator settings and initiated norepinephrine for vasopressor support. Which nursing intervention is most critical to prioritize in this scenario?

A) Monitoring arterial blood gases (ABGs) for changes in pH and PaCO2

B) Administering prescribed diuretics to manage fluid overload

C) Encouraging family presence to provide psychological support to the patient

D) Preparing for potential intubation due to the patient's unstable respiratory status

bmt infusion - Nursing Case Study

Pathophysiology

• Primary mechanism: Bone marrow transplant (BMT) infusion involves the intravenous introduction of healthy hematopoietic stem cells to restore bone marrow function in patients with conditions like leukemia. These stem cells home to the bone marrow, engraft, and proliferate to replenish blood cell lineages.

• Secondary mechanism: The infused stem cells can differentiate into various blood cells, including red blood cells, white blood cells, and platelets, effectively replacing the patient's diseased or damaged marrow with functional cells, crucial for immune competence and hematopoiesis.

• Key complication: Graft-versus-host disease (GVHD) may occur when donor immune cells attack the recipient’s tissues, leading to potential damage of skin, liver, and gastrointestinal tract, necessitating careful monitoring and immunosuppressive therapy.

Patient Profile

Demographics:

45-year-old female, school teacher

History:

• Key past medical history: Diagnosed with acute myeloid leukemia 18 months ago; completed chemotherapy 6 months ago

• Current medications: Tacrolimus, Mycophenolate mofetil, Acyclovir, Fluconazole

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Fever and fatigue post-bone marrow transplant infusion

• Key symptoms: Shortness of breath, mild chest discomfort, occasional headache

• Vital signs: Temperature 101.3°F, Heart rate 110 bpm, Blood pressure 95/60 mmHg, Respiratory rate 22 breaths per minute, Oxygen saturation 92% on room air

Section 1

As the patient continued to experience fever and fatigue following her bone marrow transplant infusion, the healthcare team conducted an initial assessment to evaluate her condition further. Physical examination revealed pallor and mild jaundice, raising concerns about potential hepatic involvement, a manifestation commonly linked to graft-versus-host disease (GVHD). Auscultation of the lungs indicated diminished breath sounds at the bases, possibly suggesting early signs of fluid accumulation or infection. The patient's oxygen saturation remained low at 92% on room air, despite supplemental oxygen, prompting the team to consider further respiratory support and investigation.

Laboratory results showed a notable increase in liver enzymes, with alanine transaminase (ALT) at 150 U/L and aspartate transaminase (AST) at 140 U/L, indicating liver stress. Complete blood count revealed leukopenia with a white blood cell count of 2,000 cells/μL, consistent with post-transplant immunosuppression. These findings raised suspicion of GVHD affecting the liver, which coupled with her respiratory symptoms, warranted an urgent chest X-ray. The imaging study revealed bilateral pulmonary infiltrates, suggesting possible infection or fluid overload, thus necessitating the consideration of antibiotics and diuretics, alongside adjustments in her immunosuppressive regimen.

Given these developments, the clinical team faced the challenge of balancing the need to mitigate GVHD while preventing opportunistic infections. This required a thoughtful reassessment of her current medications, with a focus on optimizing doses of Tacrolimus and Mycophenolate mofetil to prevent further immune-related complications. The team decided to initiate broad-spectrum antibiotic therapy to address the potential infection and closely monitor her response, preparing for additional interventions such as bronchoscopy or liver biopsy if her condition did not improve. This phase of the patient's journey highlighted the intricate interplay between managing transplant-related complications and ensuring adequate immune function to combat infections.

Section 2

As the healthcare team continued to monitor the patient's condition, her clinical status began to evolve, signaling the development of new complications. Despite the initiation of broad-spectrum antibiotics and diuretics, the patient's fever persisted, and her respiratory status deteriorated further. Her oxygen saturation dropped to 88% on room air, even with supplemental oxygen, and she exhibited increased work of breathing with accessory muscle use. A repeat chest X-ray showed worsening bilateral pulmonary infiltrates, raising the possibility of acute respiratory distress syndrome (ARDS) or worsening pulmonary infection.

Simultaneously, the patient developed new-onset abdominal discomfort and increasing jaundice, prompting further evaluation of her hepatic function. Follow-up laboratory tests revealed a continued upward trend in liver enzymes, with ALT rising to 220 U/L and AST reaching 210 U/L. Total bilirubin was elevated at 3.5 mg/dL, indicating worsening liver involvement. The healthcare team considered the possibility of veno-occlusive disease (VOD), a serious complication post-transplant, which required immediate attention. To differentiate between worsening GVHD and VOD, a liver ultrasound was ordered, revealing evidence of hepatic congestion.

In light of these developments, the clinical team faced the complex task of refining the patient’s management plan. They adjusted her immunosuppressive regimen, considering a reduction in Mycophenolate mofetil to mitigate potential hepatotoxicity while cautiously increasing Tacrolimus to control GVHD. Additionally, the team initiated supportive measures for suspected VOD, including defibrotide, and prepared for potential escalation to mechanical ventilation due to respiratory decline. This multifaceted approach underscored the necessity for ongoing reassessment and the balancing act required to navigate the intricacies of post-transplant care, highlighting the need for vigilant monitoring and timely intervention.

Section 3

As the clinical team continued to address the patient's complex post-transplant complications, new diagnostic results emerged that provided further insight into her condition. The liver ultrasound showing hepatic congestion aligned with the suspicion of veno-occlusive disease (VOD), but the team also considered the overlapping symptoms with graft-versus-host disease (GVHD). The patient's liver biopsy confirmed the presence of VOD, with centrilobular necrosis and sinusoidal obstruction, necessitating the continuation of defibrotide therapy. Further lab results showed a coagulation profile indicating elevated INR at 1.7 and decreased platelet count dropping to 45,000/mm³, suggesting a coagulopathy likely related to her liver dysfunction.

In parallel, the patient's respiratory status continued to decline, prompting a repeat arterial blood gas analysis which demonstrated severe hypoxemia with a pO2 of 58 mmHg and respiratory acidosis with a pH of 7.28. The chest X-ray revealed further progression of bilateral infiltrates, consistent with acute respiratory distress syndrome (ARDS). Given the critical nature of her respiratory compromise, the healthcare team decided to initiate non-invasive positive pressure ventilation in an attempt to stabilize her oxygenation status while preparing for potential intubation should her condition not improve.

These developments required the clinical team to reassess the patient's medication regimen and supportive care strategies. The decision was made to further optimize her diuretic therapy to manage fluid overload while ensuring renal function was closely monitored, given her increasing creatinine levels reaching 1.9 mg/dL. The interdisciplinary team also discussed the need for potential escalation in immunosuppression adjustments, weighing the risks of infection against controlling the aggressive GVHD. These strategic interventions highlighted the delicate balance in managing such a critically ill post-transplant patient, emphasizing the importance of vigilant monitoring and swift adaptation to the evolving clinical picture.

Section 4

As the clinical team continued to closely monitor the patient, new complications emerged that required immediate attention. Despite the initiation of non-invasive positive pressure ventilation, the patient's respiratory status further deteriorated. Her oxygen saturation levels dropped to 82%, and she showed signs of increased work of breathing, with accessory muscle use and tachypnea at 32 breaths per minute. The decision was made to proceed with intubation to secure her airway and provide adequate ventilation. This step was critical given her worsening ARDS and the need to maintain optimal oxygen delivery to her tissues.

Simultaneously, the patient's liver function tests showed further derangement, with bilirubin levels climbing to 6.2 mg/dL and ALT rising to 250 U/L. These findings, alongside her persistent coagulopathy and thrombocytopenia, suggested a worsening of the hepatic involvement. The team initiated discussions on the potential need for plasmapheresis and intensification of her defibrotide therapy to mitigate the effects of VOD. Additionally, her renal function showed signs of further compromise, with creatinine levels increasing to 2.3 mg/dL, prompting the initiation of renal protective strategies and close fluid management to prevent further decline.

These developments necessitated a comprehensive review of her current medication regimen, particularly focusing on balancing immunosuppression to manage the GVHD while minimizing the risk of infection. The team decided to adjust her corticosteroid dosage, aiming to achieve better control of her immune response. This adjustment, coupled with the supportive measures being employed, underscored the dynamic nature of her clinical management, requiring constant reassessment and adaptation to her rapidly changing condition. As the patient remained in a critical state, the clinical team prepared for potential further complications, emphasizing the need for vigilant monitoring and timely interventions.

Section 5

As the patient continued to receive intensive care, her clinical status evolved, presenting new challenges for the medical team. Despite intubation and mechanical ventilation, her respiratory parameters remained unstable, with persistent hypoxemia and arterial blood gas analysis revealing a pH of 7.30, PaCO2 of 55 mmHg, and PaO2 of 58 mmHg. These findings indicated a mixed respiratory and metabolic acidosis, prompting the team to adjust ventilator settings to improve ventilation and oxygenation. The decision was made to implement a lung-protective ventilation strategy, incorporating lower tidal volumes and higher positive end-expiratory pressure (PEEP) to optimize her respiratory mechanics while minimizing further lung injury.

Simultaneously, the patient developed new complications in the form of hemodynamic instability. Her blood pressure began to trend downward, with readings averaging 85/50 mmHg, accompanied by a heart rate of 118 beats per minute. These changes suggested the onset of distributive shock, likely exacerbated by her ongoing systemic inflammatory response. In response, the team initiated vasopressor support with norepinephrine to maintain adequate perfusion pressure and tissue oxygenation. This intervention required careful titration and frequent reassessment of her hemodynamic status to balance the risks of vasoconstriction with the need for maintaining perfusion to vital organs.

As these interventions were implemented, the team remained vigilant for further signs of deterioration. The patient's laboratory results showed an increase in inflammatory markers, with C-reactive protein climbing to 150 mg/L and ferritin levels rising to 2000 ng/mL, indicative of significant inflammatory activity. These findings, along with her clinical presentation, prompted the consideration of additional immunomodulatory therapies to manage her systemic inflammation and potential cytokine release syndrome. The dynamic nature of her condition required ongoing multidisciplinary collaboration, with each team member contributing to the formulation and adjustment of her comprehensive care plan.